It reschedules marijuana from Schedule 1 to Schedule 2.
It allows banking institutions to process transactions with legitimate state regulated cannabis based businesses.
It increases availability of marijuana for FDA approved research projects, and allows VA Medical Center doctors to advise and assist patients regarding use of medical marijuana in states where it is legal.
Marijuana research is currently hindered in the U.S. because of a process that requires scientists to go through an additional layer of review by the Public Health Service. There is only access to a single source of the drug, the National Institute on Drug Abuse (NIDA). The new law would result in the licensing of 3 additional sources of cannabis, reducing regulatory barriers to research.
23 states and the District of Columbia have legalized medical marijuana. Another dozen states have passed or are in the process of passing legislation regulating the use of cannabidiol oils.
The CARERS Act bills have now moved to the committee level in the U.S. Senate and House. Additional support is needed to help them emerge for a full vote.
If this issue matters to you, please join with the cannabis refugee families and encourage your elected federal officials in the Senate and House to sign on as additional co-sponsors.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
1
1
1
